相关实验视频

Updated: May 29, 2025

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

高剂量他类药物治疗对动脉内膜介质厚度的可能调节影响:一项初步研究

Tomasz K Urbanowicz¹, Katarzyna Gabriel², Ievgen Spasenenko²

¹Cardiac Surgery and Transplantology Department, Poznan University of Medical Sciences, Poznan, Poland.

Postepy w kardiologii interwencyjnej = Advances in interventional cardiology

|February 3, 2025

概括

长期高剂量他类药物治疗,包括罗斯瓦斯塔丁或阿托瓦斯塔丁,在心力衰竭患者中与心脏内膜介质厚度 (CIMT) 的降低有关. 这表明他类药物可能有助于管理动脉样硬化标志物.

科学领域:

心脏病学心脏病学
血管生物学血管生物学
药理学药理学是指药理学的学科.

背景情况:

心血管疾病 (CVD) 是一个主要的健康问题,心动脉内膜介质厚度 (CIMT) 作为一个关键指标.
类药物已被证明是降脂剂,可以降低心血管疾病风险并促进动脉样硬化斑块回归.

研究的目的:

调查长期高剂量他类药物治疗和CIMT在心力衰竭患者与保留射出小部分 (HFpEF) 之间的关系.

主要方法:

对77名HFpEF患者 (NYHA类2) 的回顾性分析,评估了临床症状.
收集的数据包括实验室测试,心声学,动脉超声波和电影血管学.
使用多变量分析和ROC曲线分析来评估CIMT和患者特征之间的关联,包括他类药物的使用.

主要成果:

超过0.8毫米的CIMT与肥胖相关 (OR = 11.86),与高他类药物治疗相反相关 (OR = 0.18).
在ROC分析表明良好的辨别能力 (AUC = 0.794) 识别患有高CIMT的患者.
高剂量他类药物治疗 (罗斯瓦斯塔丁≥20毫克/天或阿托瓦斯塔丁≥40毫克/天) 与CIMT>0.8毫米的可能性较低有关.

结论:

长期高剂量他类药物的使用与HFpEF患者的CIMT降低有关.
这些发现表明,他类型和剂量是这种关联的重要因素.
这支持了他类药物在控制该患者群体中亚临床动脉样硬化标志物的作用.

关键词:

亚托尔瓦斯塔丁是一种动脉内心介质的厚度动脉内心介质的厚度亲密到媒体的复杂.罗苏瓦斯塔丁是一种常态.类药物类药物类药物

更多相关视频

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

Published on: February 7, 2015

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

相关概念视频

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...